No Surprises in Cameco's Results

The narrow-moat firm's financial results will remain weak as long as the uranium markets struggle.

Securities In This Article
Cameco Corp
(CCJ)

Despite production cutback announcements by

As has been the theme in recent quarters, there was little that surprised us in its fourth quarter’s earnings release. Cameco’s financial results will remain weak as long as the uranium markets struggle.

Although we’ve made adjustments to our near-term forecast based on updated management guidance, our long-term forecast remains intact. We continue to expect a cumulative supply deficit to hit the uranium market by 2023. Due to the long-term nature of uranium contracts, we’d expect to see prices begin improving in 2019 in order to incentivize enough new supply.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

More in Stocks

About the Author

Kristoffer Inton

Strategist
More from Author

Kristoffer Inton is a strategist, AM Consumer, for Morningstar*. He covers food, tobacco, and cannabis companies. He also serves as the chair of Morningstar equity research’s ESG methodology.

Before joining Morningstar in 2013, Inton was an investment banking associate for Guggenheim Securities in New York. Previously, he was an investment banking analyst for Merrill Lynch in Chicago and New York. In these roles, he helped advise companies on mergers, acquisitions, and financings.

Inton holds a bachelor's degree in finance with high honors from the University of Illinois Gies College of Business. He also holds a Master of Business Administration with distinction from Northwestern University's Kellogg School of Management.

* Morningstar Research Services LLC (“Morningstar”) is a wholly owned subsidiary of Morningstar, Inc

Sponsor Center